Atasi De Chatterjee1,2, Debarshi Roy1,2, Priscilla Guevara1,2, Rituraj Pal3,2, Mahesh Naryan3,2, Sukla Roychowdhury1,2, Siddhartha Das1,2. 1. Department of Biological Sciences, Research Center, University of Texas at El Paso, El Paso, TX 79968-0519, USA. 2. The Border Biomedical Research Center, University of Texas at El Paso, El Paso, TX 79968-0519, USA. 3. Department of Chemistry, Research Center, University of Texas at El Paso, El Paso, TX 79968-0519, USA.
Abstract
BACKGROUND: The migration of tumor cells is critical in spreading cancers through the lymphatic nodes and circulatory systems. Although arachidonic acid (AA) and its soluble metabolites have been shown to induce the migration of breast and colon cancer cells, the mechanism by which it induces such migration has not been fully understood. OBJECTIVE: The effect of AA on migratory responses of the MDA-MB-231 cell line (a triple-negative breast cancer cell) was examined and compared with MCF-7 (estrogen-receptor positive) breast cancer cells to elucidate the mechanism of AA-induced migration. METHODS: Migrations of breast cancer cells were examined with the help of wound-healing assays. AA-induced eicosanoid synthesis was monitored by RP-HPLC. Cellular localizations of lipoxygenase and lipid rafts were assessed by immunoblot and confocal microscopy. RESULTS: AA treatment stimulated the synthesis of leukotriene B4 (LTB4) and HETE-8, but lowered the levels of prostaglandin E2 (PGE2), prostaglandin D2 (PGD2), and HETE-5 in MDA-MB-231 cells. Further analysis indicated that AA increased the expression of 5-lipoxygenase (5-LOX) in this cell line and inhibiting its expression by small molecule inhibitors lowered the production of LTB4 and reduced migration. In contrast, MCF-7 cells did not show any appreciable changes in eicosanoid synthesis, 5-LOX expression, or cellular migration. CONCLUSION: Our results suggest that AA treatment activates the BLT1 receptor (present in membrane microdomains) and stimulates the synthesis of LTB4 production, which is likely to be associated with the migration of MDA-MB-231 cells.
BACKGROUND: The migration of tumor cells is critical in spreading cancers through the lymphatic nodes and circulatory systems. Although arachidonic acid (AA) and its soluble metabolites have been shown to induce the migration of breast and colon cancer cells, the mechanism by which it induces such migration has not been fully understood. OBJECTIVE: The effect of AA on migratory responses of the MDA-MB-231 cell line (a triple-negative breast cancer cell) was examined and compared with MCF-7 (estrogen-receptor positive) breast cancer cells to elucidate the mechanism of AA-induced migration. METHODS: Migrations of breast cancer cells were examined with the help of wound-healing assays. AA-induced eicosanoid synthesis was monitored by RP-HPLC. Cellular localizations of lipoxygenase and lipid rafts were assessed by immunoblot and confocal microscopy. RESULTS: AA treatment stimulated the synthesis of leukotriene B4 (LTB4) and HETE-8, but lowered the levels of prostaglandin E2 (PGE2), prostaglandin D2 (PGD2), and HETE-5 in MDA-MB-231 cells. Further analysis indicated that AA increased the expression of 5-lipoxygenase (5-LOX) in this cell line and inhibiting its expression by small molecule inhibitors lowered the production of LTB4 and reduced migration. In contrast, MCF-7 cells did not show any appreciable changes in eicosanoid synthesis, 5-LOX expression, or cellular migration. CONCLUSION: Our results suggest that AA treatment activates the BLT1 receptor (present in membrane microdomains) and stimulates the synthesis of LTB4 production, which is likely to be associated with the migration of MDA-MB-231 cells.
Entities:
Keywords:
Breast cancer; MCF-7; MDA-MB-231; eicosanoids; leukotrienes; lipid rafts
Authors: Jian-Ming Lü; Jacobo Nurko; Sarah M Weakley; Jun Jiang; Panagiotis Kougias; Peter H Lin; Qizhi Yao; Changyi Chen Journal: Med Sci Monit Date: 2010-05
Authors: Robert G Sitrin; Sarah L Emery; Timothy M Sassanella; R Alexander Blackwood; Howard R Petty Journal: J Immunol Date: 2006-12-01 Impact factor: 5.422
Authors: Manali S Bendre; Aaron G Margulies; Brandon Walser; Nisreen S Akel; Sudeepa Bhattacharrya; Robert A Skinner; Frances Swain; Vishnu Ramani; Khalid S Mohammad; Lisa L Wessner; Alfredo Martinez; Theresa A Guise; John M Chirgwin; Dana Gaddy; Larry J Suva Journal: Cancer Res Date: 2005-12-01 Impact factor: 12.701
Authors: Eric C Cheon; Khashayarsha Khazaie; Mohammad W Khan; Matthew J Strouch; Seth B Krantz; Joseph Phillips; Nichole R Blatner; Laura M Hix; Ming Zhang; Kristen L Dennis; Mohammed R Salabat; Michael Heiferman; Paul J Grippo; Hidayatullah G Munshi; Elias Gounaris; David J Bentrem Journal: Cancer Res Date: 2011-01-07 Impact factor: 12.701
Authors: André Luis Lacerda Bachi; Fabiana Jin Kyung Kim; Suely Nonogaki; Célia Regina Whitaker Carneiro; José Daniel Lopes; Miriam Galvonas Jasiulionis; Mariangela Correa Journal: Mol Cancer Res Date: 2009-09-08 Impact factor: 5.852
Authors: Carlos Cantonero; Jose Sánchez-Collado; Jose J Lopez; Ginés M Salido; Juan A Rosado; Pedro C Redondo Journal: Int J Mol Sci Date: 2020-05-07 Impact factor: 5.923